Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-007683

CHIEF OPERATING OFFICER sold 6,667 shares at $21.44 ($142,936)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2025-03-07 Sale 10b5-1 −6,667 $21.44 $142,936 323,310 I: show line 1 in the form
Open-market sales · 6,667 sh · avg $21.44 · $142,936
Loading xslF345X05/form4-03112025_090341.xml…